💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 485 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
485
Toplam Hisse
$3.2T
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 3/5 (Toplam: 485)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | $294.58M | $3.78 | 0.53% | |
| OLMA | Olema Pharmaceuticals, Inc. | $293.27M | $5.28 | 0.38% | |
| MRVI | Maravai LifeSciences Holdings, Inc. | $287.92M | $2.25 | 5.06% | |
| ITOS | iTeos Therapeutics, Inc. | $285.71M | $10.02 | 0.10% | |
| RZLT | Rezolute, Inc. | $285.03M | $4.12 | 0.84% | |
| ABEO | Abeona Therapeutics Inc. | $274.74M | $6.24 | 1.30% | |
| CMPX | Compass Therapeutics, Inc. | $273.80M | $2.10 | 0.94% | |
| HRTX | Heron Therapeutics, Inc. | $266.99M | $1.88 | 1.57% | |
| TSVT | 2seventy bio, Inc. | $266.15M | $5.00 | 0.00% | |
| AURA | Aura Biosciences, Inc. | $264.41M | $5.86 | 3.78% | |
| RNAC | Cartesian Therapeutics, Inc. | $259.41M | $9.56 | 4.40% | |
| ALLO | Allogene Therapeutics, Inc. | $247.14M | $1.17 | 0.85% | |
| LFCR | Lifecore Biomedical, Inc. | $245.48M | $6.77 | 1.17% | |
| ALMS | Alumis Inc. Common Stock | $242.66M | $3.50 | 10.49% | |
| GLUE | Monte Rosa Therapeutics, Inc. | $242.66M | $4.18 | 1.18% | |
| TERN | Terns Pharmaceuticals, Inc. | $241.93M | $3.11 | 0.32% | |
| GOSS | Gossamer Bio, Inc. | $239.72M | $1.11 | 1.77% | |
| OMER | Omeros Corporation | $238.76M | $3.09 | 6.93% | |
| FHTX | Foghorn Therapeutics Inc. | $236.26M | $4.08 | 5.56% | |
| MXCT | MaxCyte, Inc. | $234.96M | $2.38 | 3.03% | |
| PHAT | Phathom Pharmaceuticals, Inc. | $233.53M | $4.25 | 1.39% | |
| THRD | Third Harmonic Bio, Inc. | $232.41M | $5.21 | 0.00% | |
| PROK | ProKidney Corp. | $228.16M | $0.72 | 0.32% | |
| AQST | Aquestive Therapeutics, Inc. | $227.44M | $2.71 | 2.87% | |
| MNPR | Monopar Therapeutics Inc. | $226.78M | $31.73 | 2.04% | |
| AVIR | Atea Pharmaceuticals, Inc. | $225.07M | $2.97 | 0.68% | |
| DRUG | Bright Minds Biosciences Inc. | $222.77M | $25.95 | 5.12% | |
| NVCT | Nuvectis Pharma, Inc. | $215.55M | $9.41 | 0.64% | |
| NGNE | Neurogene Inc. | $213.93M | $17.01 | 9.23% | |
| CDXS | Codexis, Inc. | $212.08M | $2.30 | 2.13% | |
| TOI | The Oncology Institute, Inc. | $210.72M | $3.19 | 0.62% | |
| SLRN | Acelyrin, Inc. | $204.34M | $2.27 | 0.00% | |
| TVGN | Tevogen Bio Holdings Inc. | $203.92M | $1.29 | 3.73% | |
| LXRX | Lexicon Pharmaceuticals, Inc. | $203.45M | $0.63 | 5.03% | |
| KOD | Kodiak Sciences Inc. | $202.61M | $3.40 | 4.76% | |
| OCGN | Ocugen, Inc. | $202.23M | $0.84 | 0.23% | |
| SLDB | Solid Biosciences Inc. | $195.69M | $3.21 | 2.73% | |
| DSGN | Design Therapeutics, Inc. | $195.57M | $3.73 | 6.98% | |
| ANNX | Annexon, Inc. | $192.00M | $2.04 | 6.42% | |
| OPRX | OptimizeRx Corporation | $190.57M | $12.14 | 0.75% | |
| CATX | Perspective Therapeutics, Inc. | $188.83M | $2.57 | 4.81% | |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $181.23M | $4.25 | 0.71% | |
| ANIK | Anika Therapeutics, Inc. | $177.98M | $11.15 | 0.98% | |
| INMB | INmune Bio, Inc. | $177.79M | $7.38 | 0.27% | |
| OABI | OmniAb, Inc. | $177.28M | $1.27 | 1.60% | |
| CTMX | CytomX Therapeutics, Inc. | $174.05M | $2.65 | 5.16% | |
| ELDN | Eledon Pharmaceuticals, Inc. | $172.46M | $3.00 | 2.91% | |
| ISPR | Ispire Technology Inc. | $165.44M | $2.52 | 2.70% | |
| TLSI | TriSalus Life Sciences, Inc. | $163.62M | $5.00 | 8.76% | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $161.87M | $39.78 | 5.33% | |
| PRME | Prime Medicine, Inc. | $161.49M | $1.18 | 6.35% | |
| INBX | Inhibrx Biosciences, Inc. | $161.41M | $13.47 | 2.04% | |
| IZTC | Invizyne Technologies Inc. Common Stock | $157.23M | $16.50 | 6.45% | |
| DERM | Journey Medical Corporation | $154.45M | $8.06 | 0.12% | |
| ESPR | Esperion Therapeutics, Inc. | $146.09M | $0.85 | 2.39% | |
| FDMT | 4D Molecular Therapeutics, Inc. | $145.69M | $3.62 | 2.43% | |
| PBYI | Puma Biotechnology, Inc. | $144.20M | $3.28 | 2.96% | |
| SLS | SELLAS Life Sciences Group, Inc. | $144.19M | $1.71 | 0.00% | |
| BIOA | BioAge Labs, Inc. | $143.04M | $3.96 | 0.50% | |
| KRRO | Korro Bio, Inc. | $139.64M | $11.42 | 2.64% | |
| TNGX | Tango Therapeutics, Inc. | $139.29M | $2.22 | 4.72% | |
| NKTX | Nkarta, Inc. | $134.82M | $1.74 | 3.87% | |
| NKTR | Nektar Therapeutics | $133.29M | $0.72 | 2.02% | |
| ACRS | Aclaris Therapeutics, Inc. | $132.10M | $1.46 | 0.00% | |
| GLSI | Greenwich LifeSciences, Inc. | $127.43M | $9.85 | 0.71% | |
| ALDX | Aldeyra Therapeutics, Inc. | $124.58M | $2.15 | 5.70% | |
| TARA | Protara Therapeutics, Inc. | $120.95M | $3.04 | 2.88% | |
| LYEL | Lyell Immunopharma, Inc. | $120.82M | $0.44 | 8.74% | |
| SCPH | scPharmaceuticals Inc. | $116.91M | $3.64 | 2.54% | |
| ATOS | Atossa Therapeutics, Inc. | $114.96M | $0.78 | 2.18% | |
| LRMR | Larimar Therapeutics, Inc. | $113.33M | $2.25 | 2.17% | |
| FATE | Fate Therapeutics, Inc. | $112.85M | $1.21 | 8.33% | |
| OBIO | Orchestra BioMed Holdings, Inc. | $112.26M | $2.85 | 0.71% | |
| ENTA | Enanta Pharmaceuticals, Inc. | $111.36M | $5.93 | 3.73% | |
| ALEC | Alector, Inc. | $110.99M | $1.33 | 6.34% | |
| LCTX | Lineage Cell Therapeutics, Inc. | $107.97M | $0.66 | 3.10% | |
| CCCC | C4 Therapeutics, Inc. | $106.51M | $1.25 | 5.30% | |
| SGMO | Sangamo Therapeutics, Inc. | $105.51M | $0.47 | 1.59% | |
| IRWD | Ironwood Pharmaceuticals, Inc. | $104.67M | $0.60 | 5.13% | |
| IVVD | Invivyd, Inc. | $101.97M | $0.94 | 10.29% | |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $99.88M | $0.72 | 0.33% | |
| COYA | Coya Therapeutics, Inc. | $99.56M | $5.33 | 0.03% | |
| RAPT | RAPT Therapeutics, Inc. | $99.23M | $0.89 | 4.84% | |
| CHRS | Coherus BioSciences, Inc. | $97.36M | $0.78 | 2.87% | |
| MGNX | MacroGenics, Inc. | $97.16M | $1.36 | 2.86% | |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $97.02M | $3.66 | 2.52% | |
| OPTN | OptiNose, Inc. | $95.91M | $9.60 | 0.00% | |
| HLVX | HilleVax, Inc. | $95.77M | $1.87 | 0.54% | |
| SGMT | Sagimet Biosciences Inc. | $95.09M | $3.55 | 1.43% | |
| AADI | Aadi Bioscience, Inc. | $94.89M | $2.05 | 2.38% | |
| IMUX | Immunic, Inc. | $93.97M | $0.66 | 2.97% | |
| GNLX | Genelux Corporation | $92.64M | $2.42 | 1.63% | |
| AGEN | Agenus Inc. | $91.84M | $3.43 | 7.19% | |
| ORMP | Oramed Pharmaceuticals Inc. | $91.51M | $2.34 | 4.93% | |
| KYTX | Kyverna Therapeutics, Inc. | $90.54M | $2.55 | 3.04% | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $89.71M | $7.42 | 2.62% | |
| SAVA | Cassava Sciences, Inc. | $89.37M | $2.01 | 1.47% | |
| TIL | Instil Bio, Inc. | $87.76M | $26.95 | 11.20% | |
| ANIX | Anixa Biosciences, Inc. | $85.97M | $2.57 | 1.53% | |
| GUTS | Fractyl Health, Inc. Common Stock | $85.71M | $1.90 | 0.00% |